Connable Office Inc. Has $410,000 Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Connable Office Inc. increased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 16.4% in the 3rd quarter, Holdings Channel.com reports. The firm owned 15,150 shares of the medical instruments supplier’s stock after acquiring an additional 2,138 shares during the quarter. Connable Office Inc.’s holdings in DENTSPLY SIRONA were worth $410,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. First Eagle Investment Management LLC increased its position in DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock worth $325,571,000 after buying an additional 3,283,965 shares during the period. Nuance Investments LLC increased its position in DENTSPLY SIRONA by 3.8% during the second quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock worth $271,019,000 after acquiring an additional 402,329 shares during the period. Cooke & Bieler LP raised its stake in DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after purchasing an additional 1,046,105 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in DENTSPLY SIRONA by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock valued at $207,995,000 after purchasing an additional 343,915 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in DENTSPLY SIRONA by 42.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after purchasing an additional 1,308,411 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 3.0 %

Shares of XRAY opened at $17.87 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60. The stock has a 50 day simple moving average of $24.21 and a 200-day simple moving average of $25.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same period in the prior year, the company posted $0.49 earnings per share. The business’s revenue for the quarter was up .4% compared to the same quarter last year. As a group, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

XRAY has been the subject of several research reports. Stifel Nicolaus reduced their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Robert W. Baird reduced their price objective on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Needham & Company LLC reduced their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Six research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.